(Q36750157)

16 August 2017

1 reference

title

Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential (English)

1 reference

16 August 2017

1 reference

Aaron M Mohs

1

0 references

author name string

Zheng-Rong Lu

series ordinal

2

1 reference

PubMed ID

17335412

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

Expert Opinion on Drug Delivery

16 August 2017

1 reference

16 August 2017

4

1 reference

16 August 2017

2

1 reference

16 August 2017

149-164

1 reference

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

16 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Blockade of current through single calcium channels by trivalent lanthanide cations. Effect of ionic radius on the rates of ion entry and exit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

The relationship between thermodynamics and the toxicity of gadolinium complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning--a comparison of methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Contrast-enhanced magnetic resonance angiography: technical considerations for optimized clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Water soluble polymers in tumor targeted delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Inulin as a carrier for contrast agents in magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

A gadolinium(III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Assessing tumor angiogenesis using macromolecular MR imaging contrast media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Measurement of tumor vascular volume and mean microvascular random flow velocity magnitude by dynamic Gd-DTPA-albumin enhanced and diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Tumor blood volume assays using contrast-enhanced magnetic resonance imaging: regional heterogeneity and postmortem artifacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Measurement of liver blood volume using a macromolecular MRI contrast agent at equilibrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Preparation and characterization of paramagnetic polychelates and their protein conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Novel paramagnetic macromolecular complexes derived from the linkage of a macrocyclic Gd(III) complex to polyamino acids through a squaric acid moiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Hemodynamic tolerance of intravascular contrast agents for magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Differentiation of capillary leak and hydrostatic pulmonary edema with a macromolecular MR imaging contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Myocardial infarction: assessment with an intravascular MR contrast medium. Work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Interstitial MR and CT lymphography with Gd-dTPA-co-alpha, omega-diaminoPEG(1450) and Gd-dTPA-co-1,6-diaminohexane polymers: preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Nano-sized MRI contrast agents with dendrimer cores

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Liposomal Gd-DTPA: preparation and characterization of relaxivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Magnetic resonance imaging of rabbit brain after intracarotid injection of large multivesicular liposomes containing paramagnetic metals and DTPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Liposomes as MR contrast agents: Pros and cons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

From monomers to micelles: investigation of the parameters influencing proton relaxivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Blood pool contrast agents for cardiovascular MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Characteristics of a New MRI Contrast Agent Prepared From Polypropyleneimine Dendrimers, Generation 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Long-circulating liposomal contrast agents for magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Thermodynamic stability and kinetic inertness of MS-325, a new blood pool agent for magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Intravascular contrast agent improves magnetic resonance angiography of carotid arteries in minipigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Contrast-enhanced magnetic resonance angiography with biodegradable (Gd-DTPA)-cystamine copolymers: comparison with MS-325 in a swine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

Magnetic Resonance Angiography With Gadomer-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.149

21 January 2018

Identifiers

DOI

10.1517/17425247.4.2.149

1 reference

16 August 2017

1 reference

PubMed ID

17335412